Pozen: FDA committee vote supports late-stage trial design for potential treatment: Drug developer Pozen Inc. ... http://twurl.nl/iix1f3
10:23 AM - 5 Nov 2010
0 replies
0 retweets
1 like
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.